Van Eck Associates Corp Organon & Co. Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Organon & Co. stock. As of the latest transaction made, Van Eck Associates Corp holds 276,732 shares of OGN stock, worth $4.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

276,732

Previous 209,281 32.23%

Holding current value

$4.08 Million

Previous $4.33 Million 9.93%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$18.65 - $23.03 $1.26 Million - $1.55 Million	67,451 Added 32.23%	276,732 $4.76 Million
Q2 2024 Jul 31, 2024	BUY	$17.45 - $21.96 $652,123 - $820,667	37,371 Added 21.74%	209,281 $4.33 Million
Q1 2024 Apr 30, 2024	SELL	$13.78 - $18.8 $1.02 Million - $1.39 Million	-73,681 Reduced 30.0%	171,910 $3.23 Million
Q4 2023 Feb 05, 2024	SELL	$10.95 - $17.32 $630,588 - $997,424	-57,588 Reduced 18.99%	245,591 $3.54 Million
Q3 2023 Nov 08, 2023	SELL	$16.59 - $23.77 $1.52 Million - $2.18 Million	-91,614 Reduced 23.21%	303,179 $5.26 Million
Q2 2023 Aug 03, 2023	BUY	$19.27 - $24.63 $2.52 Million - $3.22 Million	130,590 Added 49.43%	394,793 $8.22 Million
Q1 2023 May 03, 2023	SELL	$21.42 - $32.08 $4.11 Million - $6.16 Million	-192,039 Reduced 42.09%	264,203 $6.21 Million
Q4 2022 Feb 08, 2023	BUY	$23.31 - $28.61 $989,835 - $1.21 Million	42,464 Added 10.26%	456,242 $12.7 Million
Q3 2022 Oct 27, 2022	SELL	$23.4 - $34.25 $4.57 Million - $6.7 Million	-195,486 Reduced 32.09%	413,778 $9.68 Million
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $8.9 Million - $10.9 Million	281,032 Added 85.62%	609,264 $20.6 Million
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $283,367 - $366,284	-9,306 Reduced 2.76%	328,232 $11.5 Million
Q4 2021 Jan 26, 2022	BUY	$28.67 - $37.13 $1.2 Million - $1.55 Million	41,705 Added 14.1%	337,538 $10.3 Million
Q3 2021 Nov 03, 2021	BUY	$28.63 - $35.64 $3.05 Million - $3.79 Million	106,368 Added 56.14%	295,833 $9.7 Million
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $5.39 Million - $7.2 Million	189,465 New	189,465 $5.73 Million

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Organon & Co. Transaction History